Safety and Pharmacokinetics Study of Anthrax Immune Globulin Intravenous (AIGIV)
Clinical trial NCT00845650 · COMPLETED
Trial details
- NCT number
- NCT00845650
- Sponsor
- Emergent BioSolutions
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2010-10-01
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.